Related Experiment Video
Updated: Jul 18, 2026

07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Aggregated low density lipoproteins decrease metalloproteinase-9 expression and activity in human coronary smooth
Marta Otero-Viñas1, Vicenta Llorente-Cortés, Ester Peña
1Cardiovascular Research Center, CSIC-ICCC-HSCSP, Barcelona, Spain.
Atherosclerosis
|December 1, 2006
Summary
Aggregated LDL (agLDL) reduces MMP-9 activity in vascular cells, potentially impacting plaque stability and vascular remodeling after injury. This finding highlights a new mechanism in atherosclerosis progression.
Area of Science:
- Cardiovascular Biology
- Atherosclerosis Research
- Cellular and Molecular Medicine
Background:
- Vascular smooth muscle cell (VSMC) function is crucial for plaque stability.
- Metalloproteinases (MMPs), particularly MMP-9, play a role in regulating VSMC migration and plaque phenotype.
- The effect of aggregated LDL (agLDL) on MMP-9 production in VSMCs is not well understood.
Purpose of the Study:
- To investigate the impact of lipid loading via agLDL internalization on MMP-9 and MMP-2 expression and activity in human VSMCs.
- To assess the consequences of agLDL exposure on VSMC migration.
Main Methods:
- Human VSMCs were exposed to aggregated LDL (agLDL) and native LDL (nLDL).
- MMP-9, MMP-2, and TIMP-1 expression and activity were analyzed.
- VSMC migration was assessed using a scratch-wound healing assay.
Main Results:
- agLDL internalization significantly down-regulated MMP-9 activity in a time- and dose-dependent manner.
- nLDL showed a similar but less sustained decrease in MMP-9 activity.
- Neither agLDL nor nLDL affected MMP-2 or TIMP-1 levels.
- agLDL exposure markedly reduced VSMC regrowth after injury, indicating inhibited migration.
Conclusions:
- Lipid loading by agLDL internalization reduces MMP-9 activity in VSMCs.
- This reduction in MMP-9 activity is associated with inhibited VSMC migration.
- agLDL-induced changes in MMP-9 may influence vascular remodeling and atherosclerotic plaque stability.
Related Concept Videos
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...